lenalidomide has been researched along with Skin Neoplasms in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 15 (68.18) | 24.3611 |
| 2020's | 4 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Cafforio, P; Felici, C; Leone, P; Passarelli, A; Racanelli, V; Tucci, M | 1 |
| Beaumont, M; Charbonnier, A; Gruson, B; Joris, M; Marmouset, V; Marolleau, JP; Merlusca, L | 1 |
| Abdulla, FR; Di Raimondo, C; Querfeld, C; Rosen, ST; Zain, J | 1 |
| Franken, MG; Gheorghe, M; Haanen, JBAG; Leeneman, B; Uyl-de Groot, CA; van Baal, PHM | 1 |
| Andreani, M; Cardot-Leccia, N; Di Filippo, Y; Lacour, JP; Long-Mira, E; Montaudié, H; Passeron, T; Richez, V | 1 |
| Chen, M; Chen, W; Jiang, Q; Li, T; Liu, Y; Peng, J; Shi, X; Wu, J; Xi, X; Yu, X; Zhang, S; Zhu, Y | 1 |
| Anusim, N; Gupta, A; Howard, G; Jaiyesimi, I | 1 |
| Bagot, M; Beylot-Barry, M; Chaby, G; Cowan, R; Dalle, S; Fox, CP; Hasan, B; Jonak, C; Knobler, R; Marreaud, S; Morris, S; Quaglino, P; Ritchie, D; Romero, PLO; Scarisbrick, J; Servitje, O; Shah, E; Stadler, R; Väkevä, L; Vermeer, MH; Whittaker, S | 1 |
| Bouscary, D; Chavarot, N; Karras, A; Lebbe, C; Thervet, E | 1 |
| Bagot, M; Barete, S; Beylot-Barry, M; Bonnet, N; Bouabdallah, R; Dalle, S; Duval-Modeste, AB; Frison, E; Grange, F; Gros, A; Ingen-Housz-Oro, S; Joly, P; Maillard, A; Maubec, E; Merlio, JP; Mermin, D; Mortier, L; Pham-Ledard, A; Quereux, G; Ram-Wolff, C; Templier, I; Vergier, B; Vially, PJ | 1 |
| Duvic, M; Fountain, E; Fowler, N; Jain, P; Mistry, H | 1 |
| Horwitz, S; Khan, N | 1 |
| Foschi, FG; Lanzi, A; Marano, G; Savini, P; Stefanini, GF | 1 |
| Boyapati, A; Khan, S; Mar, A; Sheridan, A | 1 |
| Attias, D; Mishchenko, E; Tadmor, T | 1 |
| Assoumou, L; Balabanian, K; Boué, F; Carlotti, A; Deback, C; Desnoyer, A; Dupin, N; Gaudin, F; Marcelin, AG; Peytavin, G; Pourcher, V | 1 |
| Farhat, MM; Le Guern, A; Lebas, D; Modiano, P; Quinchon, JF | 1 |
| Agarwala, SS; Atkins, MB; Bedikian, AY; Glaspy, J; Jungnelius, JU; Knight, RD; O'Day, S; Richards, JM | 1 |
| Eisen, T; Glaspy, J; Hamilton, A; Hersey, P; Jungnelius, JU; Knight, RD; Millward, M; Trefzer, U | 1 |
| Boué, F; Castilla, MA; Kirstetter, M; Martinez, V; Melica, G; Tateo, M | 1 |
| Bartlett, JB; Clarke, IA; Dalgleish, AG; Dredge, K; Kristeleit, H; Michael, A; Muller, GW; Nicholson, S; Pandha, H; Polychronis, A; Stirling, DI; Zeldis, J | 1 |
| Laffitte, E | 1 |
1 review(s) available for lenalidomide and Skin Neoplasms
| Article | Year |
|---|---|
A systematic literature review and network meta-analysis of effectiveness and safety outcomes in advanced melanoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azetidines; Benzimidazoles; Cancer Vaccines; Carboplatin; Dacarbazine; gp100 Melanoma Antigen; Humans; Hydrazines; Imidazoles; Interleukin-2; Ipilimumab; Lenalidomide; Melanoma; Network Meta-Analysis; Nitrosourea Compounds; Nivolumab; Organophosphorus Compounds; Oximes; Paclitaxel; Piperidines; Progression-Free Survival; Proportional Hazards Models; Pyridones; Pyrimidinones; Skin Neoplasms; Sorafenib; Survival Rate; Temozolomide; Treatment Outcome; Vemurafenib | 2019 |
6 trial(s) available for lenalidomide and Skin Neoplasms
| Article | Year |
|---|---|
A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs.
Topics: Aged; Angiogenesis Inhibitors; Cytoreduction Surgical Procedures; Disease Progression; Disease-Free Survival; Female; Humans; Lenalidomide; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Skin Neoplasms; Thalidomide | 2017 |
A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type.
Topics: Aged; Aged, 80 and over; Biopsy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; France; Humans; Immunologic Factors; Leg; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Remission Induction; Skin; Skin Neoplasms; Survival Rate; Treatment Outcome | 2018 |
Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesions.
Topics: Adult; Angiogenesis Inhibitors; Antigens, Viral; Biomarkers, Tumor; Case-Control Studies; Chemokine CXCL12; Female; Humans; Lenalidomide; Male; Nuclear Proteins; Receptors, CXCR; Receptors, CXCR4; Sarcoma, Kaposi; Skin Neoplasms; Thalidomide; Vascular Endothelial Growth Factor A | 2016 |
Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma.
Topics: Antineoplastic Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Lenalidomide; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Retreatment; Skin Neoplasms; Survival Analysis; Thalidomide | 2009 |
Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma.
Topics: Antineoplastic Agents; Disease Progression; Double-Blind Method; Drug Resistance, Neoplasm; Female; Humans; Lenalidomide; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Recurrence; Retreatment; Skin Neoplasms; Thalidomide | 2010 |
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Cytokines; Female; Fibroblast Growth Factor 2; Humans; Immunization; Lenalidomide; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasms; Safety; Skin Neoplasms; T-Lymphocytes; Thalidomide; Vascular Endothelial Growth Factor A | 2004 |
15 other study(ies) available for lenalidomide and Skin Neoplasms
| Article | Year |
|---|---|
Lenalidomide arrests cell cycle and modulates PD1-dependent downstream mTOR intracellular signals in melanoma cells.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Lenalidomide; Melanoma; Programmed Cell Death 1 Receptor; Skin Neoplasms; TOR Serine-Threonine Kinases | 2023 |
The lenalidomide/bortezomib/dexamethasone regimen for the treatment of blastic plasmacytoid dendritic cell neoplasm.
Topics: Aged, 80 and over; Allografts; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Breast Neoplasms; Combined Modality Therapy; Dendritic Cells; Dexamethasone; Drug Synergism; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Lenalidomide; Male; Middle Aged; Neoplasms, Glandular and Epithelial; Neoplasms, Second Primary; Off-Label Use; Skin Neoplasms | 2019 |
Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B-cell lymphoma, leg type.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Humans; Leg; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Male; Rituximab; Salvage Therapy; Skin Neoplasms | 2019 |
Reactive angioendotheliomatosis revealing a glomerulopathy secondary to a monoclonal gammopathy successfully treated with lenalidomide.
Topics: Hemangioendothelioma; Humans; Lenalidomide; Paraproteinemias; Skin Neoplasms | 2021 |
Synchronous diagnosis of anaplastic large cell lymphoma and multiple myeloma in a patient: A case report.
Topics: Abdominal Wall; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Examination; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunohistochemistry; Lenalidomide; Lymphoma, Large-Cell, Anaplastic; Maintenance Chemotherapy; Middle Aged; Multiple Myeloma; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Prednisone; Remission Induction; Skin Neoplasms; Transplantation, Autologous; Vincristine | 2020 |
Extranodal blastoid/pleomorphic variant of mantle cell lymphoma involving the testis and skin.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Humans; In Situ Hybridization, Fluorescence; Lenalidomide; Lymphoma, Mantle-Cell; Male; Oncogene Proteins, Fusion; Orchiectomy; Positron-Emission Tomography; Prednisone; Proto-Oncogene Proteins c-myc; Radiotherapy; Rituximab; Skin Neoplasms; Testicular Neoplasms; Vincristine | 2021 |
Bortezomib Does Not Prevent the Occurrence of Kaposi's Sarcoma in Patients with Haematological Malignancies: Two Case Reports.
Topics: Aged; Amyloidosis; Antineoplastic Agents; Bortezomib; Female; Humans; Immunologic Factors; Lenalidomide; Middle Aged; Multiple Myeloma; Neoplasms, Multiple Primary; Sarcoma, Kaposi; Skin Neoplasms; Thalidomide | 2017 |
Response to pembrolizumab and lenalidomide in advanced refractory mycosis fungoides.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Humans; Immunophenotyping; Lenalidomide; Male; Mycosis Fungoides; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Treatment Outcome | 2019 |
Immunotherapy in mycosis fungoides: opening night or dress rehearsal?
Topics: Antibodies, Monoclonal, Humanized; Humans; Immunotherapy; Lenalidomide; Mycosis Fungoides; Skin Neoplasms | 2019 |
Lenalidomide monotherapy in relapsed primary cutaneous diffuse large B cell lymphoma-leg type.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Female; Humans; Leg; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Skin Neoplasms; Thalidomide | 2014 |
Reactive angioendotheliomatosis associated with cyroglobulinemia in a marathon runner.
Topics: Aged; Angiogenesis Inhibitors; Cryoglobulinemia; Hemangioendothelioma; Humans; Lenalidomide; Male; Running; Skin Neoplasms; Thalidomide | 2013 |
Response of cutaneous lesion of mantle cell lymphoma to lenalidomide.
Topics: Aged, 80 and over; Humans; Immunologic Factors; Lenalidomide; Lymphoma, Mantle-Cell; Male; Skin; Skin Neoplasms; Thalidomide | 2014 |
[Cutaneous involvement in plasma cell leukaemia].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Female; Humans; Leg; Lenalidomide; Leukemia, Plasma Cell; Leukemic Infiltration; Skin Neoplasms; Treatment Outcome | 2017 |
Lenalidomide in treating AIDS-related Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; HIV-1; Humans; Lenalidomide; Sarcoma, Kaposi; Skin Neoplasms; Thalidomide | 2011 |
Thalidomide in Kaposi sarcoma: promising or disappointing?
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Humans; Lenalidomide; Sarcoma, Kaposi; Skin Neoplasms; Thalidomide | 2007 |